Article thumbnail

Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery

By Nabil Dib, Harris Khawaja, Samantha Varner, Megan McCarthy and Ann Campbell

Abstract

The field of myocardial regeneration utilizing novel cell-based therapies, gene transfer, and growth factors may prove to play an important role in the future management of ischemic heart disease and cardiomyopathy. Phases I and II clinical trials have been published for a variety of biologics utilizing four methods of delivery: systemic infusion, intracoronary infusion, transvenous coronary sinus, and intramyocardial. This review discusses the advantages and disadvantages of the delivery approaches above

Topics: Article
Publisher: Springer US
OAI identifier: oai:pubmedcentral.nih.gov:3047684
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles